340 related articles for article (PubMed ID: 32721992)
21. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
22. The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models.
Abed Y; Bouhy X; L'Huillier AG; Rhéaume C; Pizzorno A; Retamal M; Fage C; Dubé K; Joly MH; Beaulieu E; Mallett C; Kaiser L; Boivin G
Antiviral Res; 2016 Aug; 132():6-12. PubMed ID: 27185624
[TBL] [Abstract][Full Text] [Related]
23. Impact of the Baloxavir-Resistant Polymerase Acid I38T Substitution on the Fitness of Contemporary Influenza A(H1N1)pdm09 and A(H3N2) Strains.
Checkmahomed L; M'hamdi Z; Carbonneau J; Venable MC; Baz M; Abed Y; Boivin G
J Infect Dis; 2020 Jan; 221(1):63-70. PubMed ID: 31419295
[TBL] [Abstract][Full Text] [Related]
24. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.
Kiso M; Shinya K; Shimojima M; Takano R; Takahashi K; Katsura H; Kakugawa S; Le MT; Yamashita M; Furuta Y; Ozawa M; Kawaoka Y
PLoS Pathog; 2010 Aug; 6(8):e1001079. PubMed ID: 20865125
[TBL] [Abstract][Full Text] [Related]
25. Total alkaloids from Alstonia scholaris inhibit influenza a virus replication and lung immunopathology by regulating the innate immune response.
Zhou HX; Li RF; Wang YF; Shen LH; Cai LH; Weng YC; Zhang HR; Chen XX; Wu X; Chen RF; Jiang HM; Wang C; Yang M; Lu J; Luo XD; Jiang Z; Yang ZF
Phytomedicine; 2020 Oct; 77():153272. PubMed ID: 32702592
[TBL] [Abstract][Full Text] [Related]
26. Oseltamivir-resistant variants of the 2009 pandemic H1N1 influenza A virus are not attenuated in the guinea pig and ferret transmission models.
Seibert CW; Kaminski M; Philipp J; Rubbenstroth D; Albrecht RA; Schwalm F; Stertz S; Medina RA; Kochs G; García-Sastre A; Staeheli P; Palese P
J Virol; 2010 Nov; 84(21):11219-26. PubMed ID: 20739532
[TBL] [Abstract][Full Text] [Related]
27. The 2008-2009 H1N1 influenza virus exhibits reduced susceptibility to antibody inhibition: Implications for the prevalence of oseltamivir resistant variant viruses.
Wu WL; Lau SY; Chen Y; Wang G; Mok BW; Wen X; Wang P; Song W; Lin T; Chan KH; Yuen KY; Chen H
Antiviral Res; 2012 Jan; 93(1):144-53. PubMed ID: 22138712
[TBL] [Abstract][Full Text] [Related]
28. Multidrug-resistant 2009 pandemic influenza A(H1N1) viruses maintain fitness and transmissibility in ferrets.
Memoli MJ; Davis AS; Proudfoot K; Chertow DS; Hrabal RJ; Bristol T; Taubenberger JK
J Infect Dis; 2011 Feb; 203(3):348-57. PubMed ID: 21208927
[TBL] [Abstract][Full Text] [Related]
29. Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
Tandel K; Sharma S; Dash PK; Parida M
J Med Virol; 2018 May; 90(5):836-843. PubMed ID: 29288584
[TBL] [Abstract][Full Text] [Related]
30. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
[TBL] [Abstract][Full Text] [Related]
31. Competitive fitness of oseltamivir-sensitive and -resistant highly pathogenic H5N1 influenza viruses in a ferret model.
Govorkova EA; Ilyushina NA; Marathe BM; McClaren JL; Webster RG
J Virol; 2010 Aug; 84(16):8042-50. PubMed ID: 20519385
[TBL] [Abstract][Full Text] [Related]
32. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
33. Epidemic of influenza A(H1N1)pdm09 analyzed by full genome sequences and the first case of oseltamivir-resistant strain in Myanmar 2017.
Kyaw Win SM; Saito R; Win NC; Lasham DJ; Kyaw Y; Lin N; Thein KN; Chon I; Odagiri T; Thein W; Kyaw LL; Tin OS; Saitoh A; Tamura T; Hirokawa C; Uchida Y; Saito T; Watanabe S; Odagiri T; Kamata K; Osada H; Dapat C; Watanabe H; Tin HH
PLoS One; 2020; 15(3):e0229601. PubMed ID: 32130243
[TBL] [Abstract][Full Text] [Related]
34. Characterization of a large cluster of influenza A(H1N1)pdm09 viruses cross-resistant to oseltamivir and peramivir during the 2013-2014 influenza season in Japan.
Takashita E; Kiso M; Fujisaki S; Yokoyama M; Nakamura K; Shirakura M; Sato H; Odagiri T; Kawaoka Y; Tashiro M
Antimicrob Agents Chemother; 2015 May; 59(5):2607-17. PubMed ID: 25691635
[TBL] [Abstract][Full Text] [Related]
35. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
[TBL] [Abstract][Full Text] [Related]
36. Competitive transmissibility and fitness of oseltamivirsensitive and resistant pandemic influenza H1N1 viruses in ferrets.
Duan S; Boltz DA; Seiler P; Li J; Bragstad K; Nielsen LP; Webby RJ; Webster RG; Govorkova EA
Influenza Other Respir Viruses; 2011 May; 5(Suppl 1):79-82. PubMed ID: 21751461
[No Abstract] [Full Text] [Related]
37. Selection of multi-drug resistant influenza A and B viruses under zanamivir pressure and their replication fitness in ferrets.
Oh DY; Panozzo J; Vitesnik S; Farrukee R; Piedrafita D; Mosse J; Hurt AC
Antivir Ther; 2018; 23(4):295-306. PubMed ID: 28195559
[TBL] [Abstract][Full Text] [Related]
38. Efficient transmission of pandemic H1N1 influenza viruses with high-level oseltamivir resistance.
Seibert CW; Rahmat S; Krammer F; Palese P; Bouvier NM
J Virol; 2012 May; 86(9):5386-9. PubMed ID: 22345446
[TBL] [Abstract][Full Text] [Related]
39. Combination Therapy with Oseltamivir and Favipiravir Delays Mortality but Does Not Prevent Oseltamivir Resistance in Immunodeficient Mice Infected with Pandemic A(H1N1) Influenza Virus.
Baz M; Carbonneau J; Rhéaume C; Cavanagh MH; Boivin G
Viruses; 2018 Nov; 10(11):. PubMed ID: 30400276
[TBL] [Abstract][Full Text] [Related]
40. Exploration of the mechanisms of Ge Gen Decoction against influenza A virus infection.
Geng ZK; Li YQ; Cui QH; DU RK; Tian JZ
Chin J Nat Med; 2019 Sep; 17(9):650-662. PubMed ID: 31526500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
